| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.719 | 27.572 | 29.890 | 34.323 | 35.099 | 32.648 | 41.443 | 44.421 | 49.578 | 51.901 |
| Total Income - EUR | 50.425 | 43.376 | 53.308 | 49.574 | 50.056 | 47.321 | 55.790 | 55.215 | 49.578 | 51.901 |
| Total Expenses - EUR | 47.472 | 40.295 | 39.227 | 32.005 | 27.710 | 25.389 | 26.133 | 23.647 | 23.938 | 28.246 |
| Gross Profit/Loss - EUR | 2.953 | 3.081 | 14.080 | 17.569 | 22.346 | 21.931 | 29.657 | 31.568 | 25.640 | 23.654 |
| Net Profit/Loss - EUR | 1.942 | 2.805 | 13.702 | 17.226 | 21.995 | 21.734 | 29.358 | 31.133 | 25.155 | 19.580 |
| Employees | 7 | 6 | 2 | 3 | 1 | 1 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Medicason S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 115.198 | 96.260 | 78.172 | 60.726 | 43.848 | 27.613 | 32.500 | 24.184 | 17.520 | 51.335 |
| Current Assets | 16.971 | 1.999 | 10.757 | 15.338 | 20.279 | 20.755 | 20.468 | 25.265 | 22.721 | 21.775 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 1.973 | 0 | 0 | 0 | 20.215 | 25.263 | 20.216 | 12.062 |
| Cash | 16.971 | 1.999 | 8.784 | 15.338 | 20.279 | 20.755 | 253 | 2 | 2.505 | 9.713 |
| Shareholders Funds | 22.893 | 5.484 | 13.755 | 17.278 | 22.046 | 21.784 | 29.406 | 31.181 | 25.203 | 19.628 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.497 | 92.774 | 1.373 | 1.592 | 951 | 906 | 12.801 | 18.268 | 15.038 | 53.482 |
| Income in Advance | 107.779 | 90.875 | 73.801 | 57.194 | 41.130 | 25.678 | 10.761 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medicason S.r.l.